Read More 1 minute read Analyst Ratings Initiation News Price Target Maxim Group Initiates Coverage On Marpai with Buy Rating, Announces Price Target of $2.5 By Benzinga Newsdesk August 1, 9:25 AM Maxim Group analyst Allen Klee initiates coverage on Marpai (NASDAQ:MRAI) with a Buy rating and announces Price Target of $2.5. MRAI
Read More 1 minute read Analyst Ratings Initiation News Price Target Deutsche Bank Initiates Coverage On Polestar Automotive with Hold Rating, Announces Price Target of $10 By Benzinga Newsdesk August 1, 6:18 AM Deutsche Bank analyst Emmanuel Rosner initiates coverage on Polestar Automotive (NASDAQ:PSNY) with a Hold rating and announces Price Target of $10. PSNY
Read More 1 minute read Analyst Ratings Initiation News Price Target HC Wainwright & Co. Initiates Coverage On Belite Bio with Buy Rating, Announces Price Target of $58 By Benzinga Newsdesk August 1, 6:08 AM HC Wainwright & Co. analyst Yi Chen initiates coverage on Belite Bio (NASDAQ:BLTE) with a Buy rating and announces Price Target of $58. BLTE
Read More 1 minute read Analyst Ratings Cannabis Initiation Markets News Price Target Cantor Fitzgerald Initiates Coverage On Flora Growth with Neutral Rating, Announces Price Target of $0.85 By Benzinga Newsdesk August 1, 5:34 AM Cantor Fitzgerald analyst Pablo Zuanic initiates coverage on Flora Growth (NASDAQ:FLGC) with a Neutral rating and announces Price Target of $0.85. FLGC
Read More 1 minute read Analyst Ratings Initiation News Price Target Berenberg Initiates Coverage On Doximity with Buy Rating, Announces Price Target of $49 By Benzinga Newsdesk July 29, 9:39 AM Berenberg analyst Dev Weerasuriya initiates coverage on Doximity (NYSE:DOCS) with a Buy rating and announces Price Target of $49. DOCS
Read More 1 minute read Analyst Ratings Initiation News Price Target Capital One Initiates Coverage On Amphastar Pharmaceuticals with Overweight Rating, Announces Price Target of $44 By Benzinga Newsdesk July 29, 9:36 AM Capital One analyst Tim Chiang initiates coverage on Amphastar Pharmaceuticals (NASDAQ:AMPH) with a Overweight rating and announces Price Target of $44. AMPH
Read More 1 minute read Analyst Ratings Initiation News Price Target HC Wainwright & Co. Initiates Coverage On Kinnate Biopharma with Buy Rating, Announces Price Target of $33 By Benzinga Newsdesk July 28, 6:21 AM HC Wainwright & Co. analyst Robert Burns initiates coverage on Kinnate Biopharma (NASDAQ:KNTE) with a Buy rating and announces Price Target of $33. KNTE
Read More 1 minute read Analyst Ratings Initiation News Price Target HC Wainwright & Co. Initiates Coverage On Vizsla Silver with Buy Rating, Announces Price Target of $1.6 By Benzinga Newsdesk July 28, 6:14 AM HC Wainwright & Co. analyst Heiko Ihle initiates coverage on Vizsla Silver (AMEX:VZLA) with a Buy rating and announces Price Target of $1.6. VZLA
Read More 1 minute read Analyst Ratings Initiation News Price Target Benchmark Initiates Coverage On Semtech with Buy Rating, Announces Price Target of $81 By Benzinga Newsdesk July 28, 5:10 AM Benchmark analyst Cody Acree initiates coverage on Semtech (NASDAQ:SMTC) with a Buy rating and announces Price Target of $81. SMTC
Read More 1 minute read Analyst Ratings Initiation News Price Target Benchmark Initiates Coverage On SKYX Platforms with Buy Rating, Announces Price Target of $15 By Benzinga Newsdesk July 28, 5:09 AM Benchmark analyst Michael Legg initiates coverage on SKYX Platforms (NASDAQ:SKYX) with a Buy rating and announces Price Target of $15. SKYX